Distribution of osteoprotegerin in unruptured intracranial aneurysms in humans: association with aneurysm wall protective remodeling

被引:0
作者
Hashimoto, Yukishige [1 ]
Karasaki, Kohei [4 ]
Hara, Takeshi [1 ]
Kobayashi, Shohei [1 ]
Kaneko, Mayumi [2 ]
Ono, Chiaki [3 ]
Matsushige, Toshinori [1 ]
Yoshizumi, Masao [5 ]
机构
[1] Hiroshima City North Med Ctr Asa Citizens Hosp, Dept Neurosurg & Intervent Neuroradiol, Hiroshima, Japan
[2] Hiroshima City North Med Ctr Asa Citizens Hosp, Dept Pathol, Hiroshima, Japan
[3] Hiroshima City North Med Ctr Asa Citizens Hosp, Dept Radiol, Hiroshima, Japan
[4] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Hiroshima, Japan
[5] Yasuda Womens Univ, Dept Nursing Sci, Hiroshima, Japan
关键词
aneurysm wall; osteoprotegerin; protective remodeling; smooth muscle cell; vascular disorders; endovascular neurosurgery; SMOOTH-MUSCLE-CELLS; CEREBRAL ANEURYSMS; RUPTURE; GROWTH;
D O I
10.3171/2023.10.JNS231410
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Aneurysm wall inflammation is associated with lesion instability in unruptured intracranial aneurysms (UIAs). However, most UIAs remain unruptured during lifelong follow-ups because of simultaneous protective remodeling against the inflammatory response. The protective effects of osteoprotegerin (OPG) in intracranial and abdominal aortic aneurysms have been suggested using rodent models; however, the role of this protein in UIAs in humans remains unclear. Herein, the authors examined the relationship between OPG expression and aneurysm wall integrity in intraoperatively resected UIAs by using immunohistochemical and immunofluorescence staining. METHODS Sixteen UIA wall tissue specimens resected between 2017 and 2022 were analyzed. Aneurysm growth was defined as an enlargement > 1 mm or an obvious morphological change over the course of more than 6 months. Three high-power fields were randomly selected from areas expressing high and low levels of OPG within the same aneurysm. To clarify the role of OPG in the human aneurysm wall, the authors compared averaged values for the following pathological features between the 2 OPG expression groups: aneurysm wall thickness, collagen, macrophages, smooth muscle cells, and transforming growth factor beta 1 (TGF-beta 1). Immunohistochemical staining within the entire tissue area was also analyzed to determine the relationships between OPG expression and different aneurysm growth patterns. Pathological findings were compared between high and low OPG expression levels using the Wilcoxon signed-rank test. RESULTS The heterogeneous expression of OPG was detected in the walls of UIAs. Lesions expressing high OPG levels had thicker aneurysm walls (327 vs 180 mu m, p = 0.002) and higher expression levels of TGF-beta 1 (8.5% vs 5.4%, p = 0.002) than those expressing low OPG levels. The expression of TGF-beta 1 was colocalized with that of OPG mainly in the tunica media. Furthermore, lesions expressing high OPG levels had larger alpha-SMA+ areas (25% vs 13%, p = 0.002). Aneurysm growth was observed in 6 of 9 UIAs with available data: whole sac expansion in 4 and secondary aneurysm formation in 2. Among the 6 UIAs with aneurysm growth, OPG expression was relatively higher in the UIAs with an internal elastic lamina than in those without (17% vs 6.9%). CONCLUSIONS Aneurysm wall integrity was associated with OPG expression in the aneurysm wall. Collectively, the study results indicated that OPG is associated with protective remodeling, which may contribute to the retention of aneurysm wall structures.
引用
收藏
页码:1745 / 1752
页数:8
相关论文
共 28 条
  • [1] Relation of osteoprotegerin to coronary calcium and aortic plaque (from The Dallas Heart Study)
    Abedin, Moeen
    Omland, Torbjorn
    Ueland, Thor
    Khera, Amit
    Aukrust, Pal
    Murphy, Sabina A.
    Jain, Tulika
    Gruntmanis, Ugis
    McGuire, Darren K.
    de Lemos, James A.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (04) : 513 - 518
  • [2] Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms
    Bumdelger, Batmunkh
    Kokubo, Hiroki
    Kamata, Ryo
    Fujii, Masayuki
    Yoshimura, Koichi
    Aoki, Hiroki
    Orita, Yuichi
    Ishida, Takafumi
    Ohtaki, Megu
    Nagao, Masataka
    Ishida, Mari
    Yoshizumi, Masao
    [J]. PLOS ONE, 2016, 11 (01):
  • [3] Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo
    Candido, Riccardo
    Toffoli, Barbara
    Corallini, Federica
    Bernardi, Stella
    Zella, Davide
    Voltan, Rebecca
    Grill, Vittorio
    Celeghini, Claudio
    Fabris, Bruno
    [J]. JOURNAL OF VASCULAR RESEARCH, 2010, 47 (03) : 252 - 261
  • [4] Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028903, 10.1371/journal.pone.0021891]
  • [5] Overexpression of transforming growth factor-β1 stabilizes already-formed aortic aneurysms -: A first approach to induction of functional healing by endovascular gene therapy
    Dai, JP
    Losy, F
    Guinault, AM
    Pages, C
    Anegon, I
    Desgranges, P
    Becquemin, JP
    Allaire, E
    [J]. CIRCULATION, 2005, 112 (07) : 1008 - 1015
  • [6] Unruptured intracranial aneurysms: development, rupture and preventive management
    Etminan, Nima
    Rinkel, Gabriel J.
    [J]. NATURE REVIEWS NEUROLOGY, 2016, 12 (12) : 699 - 713
  • [7] Remodeling of saccular cerebral artery aneurysm wall is associated with rupture -: Histological analysis of 24 unruptured and 42 ruptured cases
    Frösen, J
    Piippo, A
    Paetau, A
    Kangasniemi, M
    Niemelä, M
    Hernesniemi, J
    Jääskeläinen, J
    [J]. STROKE, 2004, 35 (10) : 2287 - 2293
  • [8] Smooth Muscle Cells and the Formation, Degeneration, and Rupture of Saccular Intracranial Aneurysm Wall-a Review of Current Pathophysiological Knowledge
    Frosen, Juhana
    [J]. TRANSLATIONAL STROKE RESEARCH, 2014, 5 (03) : 347 - 356
  • [9] Saccular intracranial aneurysm: pathology and mechanisms
    Frosen, Juhana
    Tulamo, Riikka
    Paetau, Anders
    Laaksamo, Elisa
    Korja, Miikka
    Laakso, Aki
    Niemela, Mika
    Hernesniemi, Juha
    [J]. ACTA NEUROPATHOLOGICA, 2012, 123 (06) : 773 - 786
  • [10] Hashimoto Y, 2021, J NEUROSURG, V136, P449